Sustained Improvement in Anemia With Low-Dose Recombinant Human Erythropoietin Therapy in a Patient With Hypoplastic Myelodysplastic Syndrome and Chromosomal Abnormalities.

Internal Medicine - Japan
doi 10.2169/internalmedicine.37.320
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Internal Medicine

Related search

Treatment of Anemia in Low Risk Myelodysplastic Syndromes With Granulocyte–macrophage Colony-Stimulating Factor Plus Recombinant Human Erythropoietin

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1999English

Autoimmune Hemolytic Anemia With Myelodysplastic Syndrome

Kansas Journal of Medicine
2013English

Empty Marrow Following Previous Irradiation in a Patient With Therapy-Related Myelodysplastic Syndrome

British Journal of Haematology
Hematology
2017English

Cryptic 5q Deletion in a Patient With Myelodysplastic Syndrome

British Journal of Haematology
Hematology
2017English

Mitral Valve Repair in a Patient With Myelodysplastic Syndrome

Annals of Thoracic and Cardiovascular Surgery
GastroenterologyCardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2011English

Maintenance Therapy With Erythropoietin for Renal Anemia

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
1994English

Significant Improvement of Takayasu Arteritis After Cord Blood Transplantation in a Patient With Myelodysplastic Syndrome

Bone Marrow Transplantation
TransplantationHematology
2013English

Clinical Efficacy of Chelation Therapy in Patients With Low-Risk Myelodysplastic Syndrome

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2019English

97 Cost-Benefit Analysis of Prevention of Neonatal Anemia With Recombinant Human Erythropoietin in Premature Infants

Pediatric Research
Child HealthPediatricsPerinatology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy